Research programme: antiviral compounds - Access
Alternative Names: Antiviral compounds research programme - AccessLatest Information Update: 19 Oct 2005
At a glance
- Originator Access Pharmaceuticals
- Class
- Mechanism of Action HIV replication inhibitors; Virus replication inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV infections; HTLV-I infections; HTLV-II infections
Most Recent Events
- 19 Oct 2005 No development reported - Preclinical for HIV infections prevention in USA (unspecified route)
- 19 Oct 2005 No development reported - Preclinical for HIV infections treatment in USA (unspecified route)
- 19 Oct 2005 No development reported - Preclinical for HTLV-I infections in USA (unspecified route)